Insulin concentrated from acid/ethanol extracts of IM-9 lymphocytes by the use of octadecylsilyl (ODS) silica cartridges averaged 0.13 ng/ml cell volume compared with the 0.12 ng insulin/ml cell culture medium. The insulin content of these cells appears to be less than 1 % of previously reported values and probably could be accounted for by concentration of insulin from the incubation medium on cell receptors. 1 suggesting that insulin concentrations in acid/ethanol extracts of whole rat brain averaged 25 times plasma insulin levels and that pork-like insulin was found in extracts of guinea pig extrapancreatic tissues at concentrations averaging 1 ng/g 2 have not been confirmed by the studies of Eng and Yalow who reported initially 3 that the insulin content of rat brain extracts averaged less than 2 ng/g and that pork-like insulin in guinea pig extrapancreatic tissues was less than 20 pg/g. 4 The use of octadecylsilyl (ODS) silica cartridges for concentration of insulin has been reported 4 to be a more satisfactory method than the previously employed 1 modification of the Mirsky method since it permits virtually quantitative recovery of the peptide from acid/ethanol extracts of tissues. In this report we have determined the insulin content of human lymphoblastoid cells of the IM-9 line both by assaying directly on acid/ethanol extract of these cells and by using a hydrophobic adsorption technique for concentration of insulin from acid/ethanol extracts of cells prior to assay. 
MATERIALS AND METHODS
The IM-9 lymphocytes were obtained from the National Institutes of Health. Cells were grown and harvested according to the method of Rosenzweig et al. 5 Cultured IM-9 lymphocytes were grown to confluence in RPMI-1640 medium with 10% fetal calf serum (FCS) centrifuged at 500 x g for 5 min, resuspended in phosphate buffered 0.85% saline (pH = 7.5) with bovine serum albumin (100 mg/dl), and recentrifuged to yield a pellet for acid/ethanol extraction. The insulin content of the medium in which the cells were subsequently to be grown was determined by radioimmunoassay. The indivudual cell volumes for the fraction were determined using a cytograph (model 3600 A, Biophysic Systems) and cell count was determined by using a hemocytometer; insulin concentration was expressed as ng per ml of cell volume. The lymphocyte cells were extracted in 0.18 N HCI-75% ethanol (acid/ethanol) by homogenization with an autoclaved Teflon grinder. The suspensions were centrifuged at 3000 x g for 30 min at 4°C and the supernatants were removed and stored at -10°C. The acid/ethanol extract of the first harvest was assayed directly. The hydrophobic adsorption technique employing ODS silica cartridges (C 18 Sep-Pak obtained from Waters Associates) 4 was used for concentration of insulin from the second cell harvest.
In the first cell harvest, the cell pellet was diluted in 10 vol of acid/ethanol prior to extraction by homogenization. The supernatant in volumes up to 25 /ul was assayed directly in a final radioimmunoassay volume of 2.5 ml. The second cell harvest was extracted similarly, except that the cell pellet was diluted in 5 vol of acid/ethanol prior to extraction.
125 Iinsulin was added to the acid/ethanol supernatant which was then diluted 1:5 with 1 M acetic acid and passed through a methanol-primed column. The column was washed with 10 ml of distilled water prior to elution with 75% alcohol/0.005 N HCI. Five successive 0.5-ml fractions were collected. Fractions 2-5 contained 90% of the total 125 l-insulin tracer. Fraction 2 contained 59% of the total radioactivity in 0.5 ml volume and was used in the assay for insulin content. In this case the final incubation volume was W. A. BAUMAN. V. B. HATCHER. M. A. LEVITT, AND R. S. YALOW 2.0 ml and a 40 /xl sample was assayed in duplicate. Acid in the samples was neutralized with equal volumes of 0.18 N NaOH in the incubation mixture for radioimmunoassay.
Radioimmunoassay was performed using two guinea pig anti-insulin sera which do not distinguish among beef, pork, and human insulins (Lilly Research Laboratory, courtesy of Dr. Mary Root). Antiserum 11-8-14 is generally used at a dilution of 1:4 x 10 6 and antiserum N3-13 at a dilution of 1:2 x 10 6 . Antiserum 11 -8-14 was used for the first cell harvest and N3-13 for the second cell harvest. With either antiserum, the minimal detectable concentration (i.e., decrease of 10% in B/F ratio) is 1-2 pg insulin/ml insulin incubation mixture. The concentration of insulin which produced a 50% displacement of the tracer was 10 pg/ml with 11-8-14 and 8 pg/ml with N3-13. Porcine monoiodoinsulin (400/i,Ci 125 l//xg) was prepared according to established methods in our laboratory and purified on starch gel electrophoresis. 6 The standard diluent for the assays was 0.02 M barbital buffer (pH 8.6) fortified with 2.5 mg human serum albumin per ml. Separation of bound from free 125 l-insulin was effected after a 4-day incubation by addition to the incubation mixture of 0.2 ml of 100 mg charcoal/ml 0.02 barbital buffer.
RESULTS
In the first study 2.6 x 10 9 cells, which represents a cell volume of 2.4 ml, were harvested. The 2 ml pellet was extracted with 18 ml acid/ethanol and 25 fi\ of the supernatant was added directly to the 2.5 ml incubation mixture. No insulin was detected in the antiserum 11-8-14 system which had a sensitivity of 2 pg/ml. Thus, the 25-/xl sample contained less than 5 pg insulin and the 20-ml extractant contained less than 4 ng. The insulin content of the IM-9 lymphocytes was therefore calculated to be less than 1.5 ng/ml cell volume.
For the second study 2.3 x 10 9 cells were harvested. This represents a cell volume of just over 2 ml. The insulin concentration in Fraction 2 of the C 18 eluate was determined to be 0.3 ng/ml. Since this fraction had a volume of 0.5 ml and contained 59% of the 125 l-insulin added to the acid/ethanol extract of the cell harvest, the insulin content of the IM-9 lymphocytes was calculated to be 0.13 ng/ml cell volume. The insulin concentration in the culture medium prior to the incubation of cells employed in the second harvest was assayed to be 0.12 ng/ml.
DISCUSSION
Rosenzweig et al. 5 have reported that the IM-9 human lymphoblastoid cell line had insulin concentrations averaging 21 ± 5 (SEM) ng/ml cell volume. This value had been corrected for insulin losses in the extraction procedure. On Sephadex gel filtration, the insulin immunoreactivity appeared to be attributable solely to a 6000-dalton peptide. There was little immunoreactivity in the void volume and no peak corresponding to proinsulin.
The method used for assaying the first harvest of IM-9 lymphocytes, permitted us only to set an upper limit of less than 1.5 ng insulin/ml cell volume. This is less than 10% of that earlier reported by Rosenzweig et al. 5 With the use of C 18 cartridges for concentrating insulin from acid/ethanol extracts of the cell pellet, the IM-9 lymphocyte insulin content was determined to be only 0.13 ng/ml cell volume, that is, less than 1% of that reported earlier. 5 The insulin content of the culture medium containing FCS was 0.12 ng/ml; this was quite comparable to that of the IM-9 cells. Therefore it seems most likely that IM-9 lymphocyte insulin content could be attributed to concentration of insulin from the medium onto the lymphocyte receptors rather than to de novo synthesis.
What can account for a hundred-fold difference in IM-9 lymphocyte insulin content as determined in the two laboratories? One possibility is that the IM-9 lymphocyte insulin is immunochemically different from beef, pork, dog, whale, or human insulins, all of which cross-react identically with the two antisera we employ. However, consideration must be given to the possibility that the higher values reported by Rosenzweig et al., 5 might be a consequence of the need to extract and concentrate large volumes, since the antiserum used in that study was of low sensitivity. From the standard curve shown, 5 it appeared that an insulin concentration of 300 pg/ml was required to reduce the B/F ratio by 50% compared with the 8-10 pg/ml required to effect the same reduction of B/F ratio in our assay systems. The possibility therefore exists that accidental contamination that could occur during the concentration of insulin from large volumes of culture medium might account for the quantitatively different results obtained in the two laboratories.
Our laboratory has not confirmed 3 -4 the earlier reports of high concentrations of insulin in rat brain 1 -5 or of pork-like insulins at concentrations of 1 ng/g in guinea pig tissues including brain. 2 In addition, in a collaborative study 7 performed in the NIH laboratory, the insulin content in 5 of 8 rat brains was less than 1 ng/g compared with the average for 20 rat brains of 10 ng/g, uncorrected for losses, previously reported from that laboratory. 5 In the other three rat brains, the immunoreactive insulin was more pork-like than rat-like, although the kidney insulin in these animals resembled immunoreactive rat insulin. Thus, the insulins extracted from brains and kidneys of these three rats behaved immunochemically as if they were from different species. The most likely explanation is that the insulin in the extracts of the brains of these three rats was not endogenous rat insulin.
The suggestion that insulin is synthesized in many nonpancreatic tissues and even in E. co// 8 is intriguing. However, precursor molecules, such as proinsulin, have not been detected following Sephadex gel filtration of these extracts.
The failure to detect proinsulin would suggest that the nonpancreatic tissues purported to synthesize insulin must either contain a mechanism for processing the peptides so rapidly as to remove the precursors or synthesize insulin directly rather than via a prohormone form, which would be both novel and contrary to what is currently known of peptide synthesis. In this regard, it should be noted that in ectopic hormone production, the relative concentration of the prohormone is generally enhanced because aberrant tissues are often deficient in posttranslational processing mechanisms. 9 The ultimate proof of extrapancreatic insulin synthesis would be the demonstration that such tissues contain the messenger RNA that codes for insulin. Recently, Giddings et al. 10 used hybridization of a cloned DNA complementary to rat proinsulin mRNA as an assay for the presence of
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EVIDENCE AGAINST INSULIN SYNTHESIS BY IM-9 LYMPHOCYTES quantification of proinsulin mRNA. These investigators examined many rat tissues inculding various subsections of brain. From their negative results, they concluded that if insulin-like molecules are synthesized in extrapancreatic tissues, their synthesis must be limited to a small subsection of the organs in which they are reported because the abundance of proinsulin mRNA is less than one part in a million total mRNA molecules. This, of course, is not consistent with the diffuse staining for insulin previously reported 1 in immunohistochemical studies in rat brain. The resolution as to whether E. coli or similar simple organisms can synthesize and process a variety of peptides, such as insulin, ACTH, and others, will ultimately depend on a complete mapping of the genetic coding of these organisms.
